News & Events :: CNS Pharmaceuticals, Inc. (CNSP)

Recent News View All News

CNS Pharmaceuticals (NASDAQ: CNSP) Reaches Milestone with Enrollment of 200 Patients in Ongoing Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

Sep 7, 2023 8:45am EDT

CNS Pharmaceuticals (NASDAQ: CNSP) to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Sep 5, 2023 8:45am EDT

Recent Events View IR Calendar

2023 Annual Meeting of Stockholders

Sep 14, 2023 • 3:00 pm EDT

H.C. Wainwright 25th Annual Global Investment Conference

Sep 13, 2023 • 10:30 am EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings